Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
Highlights of the PCI news focused on Penn commercialization accomplishments
During his time at PCI, David worked on a wide range of projects and hopes to eventually establish an innovation hub in Africa that will address intellectual property issues for Africans.
Penn Engineering’s Boon Thau Loo, PhD, Senior Associate Dean for Education and Global Initiatives, was featured in Technical.ly Philly for his deep personal experiences with academic entrepreneurship.
The 2022 President’s Sustainability Prize winner Shinkei Systems was recognized in a recent article by Tech Crunch for its role in changing the seafood industry.
EpiVario is developing neuroepigenetic modulators to treat memory-related addiction and psychiatric disorders.
Interius intends to begin patient enrollment for the trial in the fourth quarter of 2024.
The collaboration combines Ascidian's RNA exon editing technology with Roche's expertise in CNS delivery to create novel treatments for hard-to-treat neurological conditions.
The company reported positive results in the first two patients who received its new CAR T therapy, CABA-201, which aims to treat the autoimmune diseases lupus and myositis.
César de la Fuente, PhD, Presidential Assistant Professor at Penn, has significantly advanced the field of antibiotic discovery through his innovative use of computational and AI-assisted techniques.
Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.
In the article, Technical.ly highlights that Penn affiliated startups attracted over $1 billion in investment capital in 2023.